The purpose of this research study is to test the safety and effectiveness of aripiprazole lauroxl in adults with schizophrenia who switch treatment from paliperidone palmitate to aripiprazole lauroxil.
Who may be Eligible
male and female ages 18-65
IRB Number
07-16-02A
Principal Investigator
Tcheremissine, Oleg
Contact Name
Dineen
For More Information, Contact Dineen , Gardner
Phone: (704) 446-7511 Fax: (704) 446-7505 Email: Dineen.Gardner@atriumhealth.org Address:465 North Wendover Road
Charlotte, NC